Sanyu Africa Research institute (SAfRI) is a registered not for profit organization whose vision is, ‘A world in which all women and children can enjoy high quality health care’. SAfRI’s mission is to improve maternal, newborn and child health especially among the poor through high quality, collaborative clinical research using low-cost innovative technologies. We work closely with local health care providers and government to strengthen the research capacity and promote inspiring models of evidence-based practice. SAfRI is inviting applications for the position of research midwife for a 2 -year cluster randomized trial. This trial aims to determine whether the use of alcohol-based hand rub in the community will reduce the occurrence of severe illness in newborns. The study will be done in Mbale and Budaka district.
Duty Station: Budaka

Sanyu Africa Research institute (SAfRI) is a registered not for profit organization whose vision is, ‘A world in which all women and children can enjoy high quality health care’. SAfRI’s mission is to improve maternal, newborn and child health especially among the poor through high quality, collaborative clinical research using low-cost innovative technologies. We work closely with local health care providers and government to strengthen the research capacity and promote inspiring models of evidence-based practice. SAfRI is inviting applications for the position of research midwife for a 2 -year cluster randomized trial. This trial aims to determine whether the use of alcohol-based hand rub in the community will reduce the occurrence of severe illness in newborns. The study will be done in Mbale and Budaka district. The Research midwife’s primary role is to recruit pregnant women into the study, provide information to the participants, obtain informed consent, and complete the data collection tools. Work closely with the hub data supervisor, trial manager, other study staff and principal investigator to ensure compliance to the protocol and required regulations.

Application Deadline: October 20th 2020